Hydrochlorothiazide Should Be Temporarily Discontinued in Patients with Acute Kidney Injury
In patients who develop acute kidney injury (AKI), hydrochlorothiazide should be temporarily discontinued until kidney function stabilizes and volume status is optimized. This recommendation is based on established guideline consensus that diuretics, including thiazides, should be stopped during serious intercurrent illness that increases AKI risk 1, 2.
Rationale for Discontinuation
The KDIGO guidelines explicitly recommend temporary discontinuation of diuretics in patients with GFR <60 mL/min/1.73 m² who have serious intercurrent illness increasing AKI risk 1. This applies directly to hydrochlorothiazide in the setting of established AKI for several key reasons:
- Thiazides are particularly ineffective in significant renal dysfunction (creatinine >221 μmol/L [>2.5 mg/dL] or eGFR <30 mL/min/1.73 m²) and may worsen kidney function 3
- Risk of volume depletion and hypotension can exacerbate AKI through decreased renal perfusion 3
- Potential for electrolyte disturbances (hypokalemia, hyponatremia) that complicate AKI management 3, 4
The ADQI consensus specifically identifies diuretics as nephrotoxins that should be discontinued when they are the potential cause of AKI or when a less nephrotoxic alternative exists 5.
When to Restart Hydrochlorothiazide
Restart hydrochlorothiazide only after:
- Serum creatinine has stabilized or is trending downward
- Volume status is optimized (euvolemic)
- Blood pressure control requires diuretic therapy
- eGFR has improved to >30 mL/min/1.73 m² (thiazides have minimal efficacy below this threshold) 3
Monitor renal function and electrolytes 1-2 weeks after restarting 3.
Alternative Treatments During AKI
If diuresis is absolutely necessary during AKI:
Loop diuretics (furosemide, bumetanide, torsemide) are preferred over thiazides because they:
- Remain effective at lower GFR levels 3, 4, 3
- Have more predictable dose-response in renal dysfunction
- Can be titrated more precisely
However, recent evidence suggests that for AKI treatment, diuretics may make little or no difference to the need for kidney replacement therapy (RR 0.93,95% CI 0.83-1.04) and may increase hypotension (RR 1.99) and arrhythmias (RR 1.62) 6. Therefore, diuretics should only be used if there is clear volume overload with pulmonary edema or symptomatic fluid retention.
For blood pressure control during AKI recovery:
- Consider calcium channel blockers or beta-blockers as alternatives
- ACE inhibitors/ARBs should also be temporarily held during AKI and reintroduced cautiously once GFR stabilizes 1, 5, 1
Important Caveats
Do not routinely discontinue diuretics in stable chronic kidney disease (CKD) patients without AKI, as they may remain nephroprotective 1. The distinction between acute injury and chronic stable disease is critical.
Avoid NSAIDs during this period, as they can worsen diuretic-induced renal impairment and cause diuretic resistance 3, 7. The combination of hydrochlorothiazide with NSAIDs and exercise has been documented to cause severe AKI 8.
Monitor for rebound hypertension when stopping hydrochlorothiazide, particularly in patients with heart failure where acute cardiac decompensation can occur 5.
The evidence for thiazide-induced direct nephrotoxicity exists but is rare, typically involving crystal deposition with massive overdose 9 or in combination with triamterene 9, 8. Standard therapeutic doses primarily cause AKI through hemodynamic effects and volume depletion.